Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1.Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006;295:1033–1041.CappolaAR]]FriedLP]]ArnoldAM&etal;Thyroid status, cardiovascular risk, and mortality in older adults.JAMA20062951033-10412.Toft AD, Boon NA. Thyroid disease and the heart. Heart 2000;84:455–460.ToftAD]]BoonNAThyroid disease and the heart.Heart200084455-4603.Schmidt-Ott UM, Ascheim DD. Thyroid hormone and heart failure. Curr Heart Fail Rep 2006;3:114–119.Schmidt-OttUM]]AscheimDDThyroid hormone and heart failure.Curr Heart Fail Rep20063114-1194.Yamamoto T. Tablet formulation of Levothyroxine is absorbed less well than powdered Levothyroxine. Thyroid 2003;13:1177–1181.YamamotoTTablet formulation of Levothyroxine is absorbed less well than powdered Levothyroxine.Thyroid2003131177-11815.Eledrisi MS, Szymajda A, Alshanti M, et al. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine. South Med J 2001;94:833–836.EledrisiMS]]SzymajdaA]]AlshantiM&etal;Noncompliance with medical treatment: pseudomalabsorption of levothyroxine.South Med J200194833-8366.Lips DJ, van Reisen MT, Voigt V, et al. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med 2004;62:114–118.LipsDJ]]van ReisenMT]]VoigtV&etal;Diagnosis and treatment of levothyroxine pseudomalabsorption.Neth J Med200462114-118
